Key facts
- WeiMai (China)’s last known valuation is $552.1M (Dec 2024).
- It has raised $204.9M; the latest was IPO in Jul 2025.
- Notable investors include IDG Capital, Baidu Ventures, Source Code Capital, Vision Plus Capital, Deqing County Industrial Development Investment Fund Management — 12 tracked in total.
- Status: In IPO Registration.
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for WeiMai (China)
- ·The full record, as it builds
Funding rounds
No funding rounds for WeiMai (China) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About WeiMai (China)
Developer of a mobile application designed to provide innovative medical services. The company's products cooperate with local hospitals to provide patients with medical services including medical consultation services, internet diagnosis and treatment services, health management and family doctor services, and on-site medical and nursing services, enabling hospitals to improve work efficiency.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2015
- Employees
- 324
- Website
- myweimai.net/
- Ownership
- In IPO Registration
WeiMai (China) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in WeiMai (China) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on WeiMai (China) in its N-PORT filings yet. We sweep new filings monthly.